Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
J. A. Lees, J. M. Dias, F. Rajamohan…·S. Han
The paper reports the first structural characterization of GPR61 and identifies a potent inverse agonist, revealing an allosteric mechanism.
L. Koppensteiner, L. Mathieson, S. Pattle…·A. R. Akram
The paper identifies CD39+ T cell sub-populations in NSCLC tumors and shows their spatial distribution correlates with patient outcomes.
L. Mathieson, L. Koppensteiner, S. Pattle…·A. R. Akram
The paper identifies CAF subtypes in NSCLC using flow cytometry and scRNA-seq, showing CAF-S1 and CAF-S5 are associated with poor patient survival.
K. J. Smith, D. Minns, B. McHugh…·E. Gwyer Findlay
This study shows cathelicidin promotes Th17 responses and severe EAE by enhancing T cell differentiation and plasticity, and its absence protects mice from disease.
B. Boras, R. M. Jones, B. J. Anson…·M. E. McGrath
This study identifies PF-00835321 as a potent inhibitor of SARS-CoV-2 3CL protease with in vitro antiviral activity and clinical evaluation potential.
M. de Vries, A. Mohamed, R. A. Prescott…·M. Dittmann
This study compares the antiviral efficacy of PF-00835231, GC-376, and remdesivir in human airway models, showing PF-00835231 is at least as potent as the others and not affected by P-glycoprotein efflux.